We are live on ! Find out more
VIRS

Pacer BioThreat Strategy ETF
VIRS

Delisted

VIRS was delisted on the 10th of October, 2024.

Back to rankings

5 hedge funds and large institutions have $528K invested in Pacer BioThreat Strategy ETF in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

8% more capital invested

Capital invested by funds: $489K → $528K (+$39K)

0% more funds holding

Funds holding: 5 → 5 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
+$85.3K
2
LF
Lee Financial
Texas
+$48.5K
3
UBS Group
UBS Group
Switzerland
+$7.51K
4
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$33

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$113K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cambridge Investment Research Advisors
1
Cambridge Investment Research Advisors
Iowa
$253K +$33 +1 +0%
Osaic Holdings
2
Osaic Holdings
Arizona
$147K +$85.3K +2,567 +131%
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$70K -$113K -3,385 -61%
LF
4
Lee Financial
Texas
$47K +$48.5K +1,458 New
UBS Group
5
UBS Group
Switzerland
$11K +$7.51K +226 +184%

VIRS Hedge Fund Activity: Q3 2021 in Review

5 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Pacer BioThreat Strategy ETF (VIRS) for Q3 2021, worth a combined $528K — up 8% from $489K a quarter earlier.

Fund positioning in VIRS was balanced in Q3 2021: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 1 trimmed.

The largest buyer was Osaic Holdings, adding an estimated $85.3K. The largest seller was Royal Bank of Canada, cutting an estimated $113K.

  • 5 institutional investors held Pacer BioThreat Strategy ETF (VIRS) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $528K of Pacer BioThreat Strategy ETF stock for Q3 2021, up 8% quarter-over-quarter.
  • 1 fund opened new Pacer BioThreat Strategy ETF positions in Q3 2021 and 1 closed out, a net change of 0 holders.
  • The largest Pacer BioThreat Strategy ETF buyer in Q3 2021 was Osaic Holdings, an estimated $85.3K added.
  • The largest Pacer BioThreat Strategy ETF seller in Q3 2021 was Royal Bank of Canada, an estimated $113K sold.

Based on aggregated 13F filings for Q3 2021.